Apoptosome inactivation rescues proneural and neural cells from neurodegeneration

Cell Death and Differentiation

Volumn 11, Issue 11, 2004, Pages 1179-1191

  Cozzolino, M ^a,b,c   Ferraro, E ^a,b   Ferri, A ^c,d   Rigamonti, D ^e   Quondamatteo, F ^f   Ding, H ^g   Xu, Z S ^g   Ferrari, F ^a,b   Angelini, D F ^c   Rotilio, G ^a   Cattaneo, E ^e   Carrii M T ^a   Cecconi, Francesco ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c Center for Experimental Neurobiology   (Italy)

^d CNR   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Apaf1; Apoptosis; Mitochondria

Indexed keywords

AMYLOID BETA PROTEIN; APOPTOSIS INDUCING FACTOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BETA TUBULIN; CELL MARKER; CYTOCHROME C; NESTIN; NOTCH1 RECEPTOR; PROTEASOME; SUPEROXIDE DISMUTASE;

ADOPTIVE IMMUNOTHERAPY; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL FATE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; ENZYME ACTIVATION; ENZYME DEGRADATION; MITOCHONDRION; MOUSE; NERVE CELL; NERVE DEGENERATION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; STEM CELL;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; BLOTTING, WESTERN; BROMODEOXYURIDINE; CASPASES; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MEMBRANE POTENTIALS; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEURONS; PEPTIDE FRAGMENTS; PLASMIDS; PROTEINS; TIME FACTORS; TRANSGENES;

EID: 7244222078     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401476     Document Type: Article

References (43)

1. Adams JM and Cory S (2002) Apoptosomes: engines for caspase activation. Curr. Opin. Cell. Biol. 14: 715-720
2. Zou H, Henzel WJ, Liu X, Lutschg A and Wang X (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413
3. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA and Gruss P (1998) Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94: 727-737
4. Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM and Mak TW (1998) Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94: 739-750
5. Honarpour N, Du C, Richardson JA, Hammer RE, Wang X and Herz J (2000) Adult Apaf-1-deficient mice exhibit male infertility. Dev. Biol. 218: 248-258
6. Kuan CY, Roth KA, Flavell RA and Rakic P (2000) Mechanisms of programmed cell death in the developing brain. Trends Neurosci. 23: 291-297
7. Yuan J and Yankner BA (2000) Apoptosis in the nervous system. Nature 407: 802-809
8. Krammer PH (2000) CD95's deadly mission in the immune system. Nature 407: 789-795
9. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ, Roy S, Nicholson DW, Vaux DL, Bouillet P, Adams JM and Strasser A (2002) Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419: 634-637
10. Guegan C and Przedborski S (2003) Programmed cell death in amyotrophic lateral sclerosis. J. Clin. Invest. 111: 153-161
11. Zimmerman L, Parr B, Lendahl U, Cunningham M, McKay R, Gavin B, Mann J, Vassileva G and McMahon A (1994) Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron 12: 11-24
12. Cattaneo E and Conti L (1998) Generation and characterization of embryonic striatal conditionally immortalized ST14A cells. J. Neurosci. Res. 53: 223-234
13. Ehrlich ME, Conti L, Toselli M, Taglietti L, Fiorillo E, Taglietti V, Ivkovic S, Guinea B, Tranberg A, Sipione S, Rigamonti D and Cattaneo E (2001) ST14A cells have properties of a medium-size spiny neuron. Exp. Neurol. 167: 215-226
14. Cleveland DW and Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2: 806-819
15. Lassus P, Opitz-Araya X and Lazebnik Y (2002) Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297: 1352-1354
16. Zhang X, Graham SH, Kochanek PM, Marion DW, Nathaniel PD, Watkins SC and Clark RS (2003) Caspase-8 expression and proteolysis in human brain after severe head injury. FASEB J. 17: 1367-1369
17. Sperandio S, de Belle I and Bredesen DE (2000) An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA 97: 14376-14381
18. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM and Kroemer G (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446
19. Cande C, Cecconi F, Dessen P and Kroemer G (2002) Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J. Cell. Sci. 115: 4727-4734
20. Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW, Dawson TM, Dawson VL, Park DS, Kroemer G and Slack RS (2002) Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell. Biol. 158: 507-517
21. Arnoult D, Gaume B, Karbowski M, Sharpe JC, Cecconi F and Youle RJ (2003) Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J. 22: 4385-4399
22. Arnoult D, Parone P, Martinou JC, Antonsson B, Estaquier J and Ameisen JC (2002) Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J. Cell. Biol. 159: 923-929
23. van Loo G, Schotte P, van Gurp M, Demol H, Hoorelbeke B, Gevaert K, Rodriguez I, Ruiz-Carrillo A, Vandekerckhove J, Declercq W, Beyaert R and Vandenabeele P (2001) Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ. 8: 1136-1142
24. Waterhouse NJ, Goldstein JC, von Ahsen O, Schuler M, Newmeyer DD and Green DR (2001) Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J. Cell. Biol. 153: 319-328
25. Ricci JE, Gottlieb RA and Green DR (2003) Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J. Cell. Biol. 160: 65-75
26. Ferraro E, Corvaro M and Cecconi F (2003) Physiological and pathological roles of Apaf1 and the apoptosome. J. Cell. Mol. Med. 7: 21-34
27. Honarpour N, Gilbert SL, Lahn BT, Wang X and Herz J (2001) Apaf-1 deficiency and neural tube closure defects are found in fog mice. Proc. Natl. Acad. Sci. USA 98: 9683-9687
28. Troy CM, Rabacchi SA, Friedman WJ, Frappier TF, Brown K and Shelanski ML (2000) Caspase-2 mediates neuronal cell death induced by beta-amyloid. J. Neurosci. 20: 1386-1392
29. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA and Yuan J (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cylotoxicity by amyloid-beta. Nature 403: 98-103
30. Martinou I, Desagher S, Eskes R, Antonsson B, Andre E, Fakan S and Martinou JC (1999) The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event. J. Cell. Biol. 144: 883-889
31. Deshmukh M, Kuida K and Johnson Jr EM (2000) Caspase inhibition extends the commitment to neuronal death beyond cytochrome c release to the point of mitochondrial depolarization. J. Cell. Biol. 150: 131-143
32. Chang LK, Schmidt RE and Johnson Jr EM (2003) Alternating metabolic pathways in NGF-deprived sympathetic neurons affect caspase-independent death. J. Cell. Biol. 162: 245-256
33. Friedlander RM (2003) Apoptosis and caspases in neurodegenerative diseases. N. Engl. J. Med. 348: 1365-1375
34. Troy CM and Salvesen GS (2002) Caspases on the brain. J. Neurosci. Res. 69: 145-150
35. Inoue H, Tsukita K, Iwasato T, Suzuki Y, Tomioka M, Tateno M, Nagao M, Kawata A, Saido TC, Miura M, Misawa H, Itohara S and Takahashi R (2003) The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model. EMBO J. 22: 6665-6674
36. Storch A and Schwarz J (2002) Neural stem cells and neurodegeneration. Curr. Opin. Investig. Drugs 3: 774-781
37. Isacson O, Bjorklund LM and Schumacher JM (2003) Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells. Ann. Neurol. 53 (Suppl 3): S135-S146; discussion S146-S138
38. Mattson MP (2000) Emerging neuroprotective strategies for Alzheimer's disease: dietary restriction, telomerase activation, and stem cell therapy. Exp. Gerontol. 35: 489-502
39. Carri MT, Ferri A, Battistoni A, Famhy L, Gabbianelli R, Poccia F and Rotilio G (1997) Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett. 414: 365-368
40. Ding H, Schwarz DS, Keene A, Affar el B, Fenton L, Xia X, Shi Y, Zamore PD and Xu Z (2003) Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2: 209-217
41. Salminen M, Meyer BI, Bober E and Gruss P (2000) Netrin 1 is required for semicircular canal formation in the mouse inner ear. Development 127: 13-22
42. Stoykova A and Gruss P (1994) Roles of Pax-genes in developing and adult brain as suggested by expression patterns. J. Neurosci. 14: 1395-1412
43. Casciati A, Ferri A, Cozzolino M, Celsi F, Nencini M, Rotilio G and Carri MT (2002) Oxidative modulation of nuclear factor-kappaB in human cells expressing mutant fALS-typical superoxide dismutases. J. Neurochem. 83: 1019-1029